Multiarm, non-randomised, single-centre feasibility study-investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocol.

Autor: Horvat-Menih I; Department of Radiology, University of Cambridge, Cambridge, UK., McLean MA; Department of Radiology, University of Cambridge, Cambridge, UK., Zamora-Morales MJ; Department of Radiology, University of Cambridge, Cambridge, UK., Wylot M; Department of Radiology, University of Cambridge, Cambridge, UK., Kaggie J; Department of Radiology, University of Cambridge, Cambridge, UK., Khan AS; Department of Radiology, University of Cambridge, Cambridge, UK., Gill AB; Department of Radiology, University of Cambridge, Cambridge, UK., Duarte J; Department of Radiology, University of Cambridge, Cambridge, UK., Locke MJ; Department of Radiology, University of Cambridge, Cambridge, UK., Mendichovszky I; Department of Radiology, University of Cambridge, Cambridge, UK.; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Li H; Department of Radiology, University of Cambridge, Cambridge, UK.; Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, Shanghai, China., Priest AN; Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Warren AY; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Welsh SJ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Jones JO; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Armitage JN; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Mitchell TJ; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Surgery, University of Cambridge, Cambridge, UK., Stewart GD; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Surgery, University of Cambridge, Cambridge, UK., Gallagher FA; Department of Radiology, University of Cambridge, Cambridge, UK fag1000@cam.ac.uk.

Publikováno v: BMJ open [BMJ Open] 2024 Oct 26; Vol. 14 (10), pp. e083980. Date of Electronic Publication: 2024 Oct 26.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

¹¹C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy.

Autor: Bashari, W. A., van der Meulen, M., MacFarlane, J., Gillett, D., Senanayake, R., Serban, L., Powlson, A. S., Brooke, A. M., Scoffings, D. J., Jones, J., O'Donovan, D. G., Tysome, J., Santarius, T., Donnelly, N., Boros, I., Aigbirhio, F., Jefferies, S., Cheow, H. K., Mendichovszky, I. A., Kolias, A. G.

Publikováno v: Pituitary; Aug2022, Vol. 25 Issue 4, p573-586, 14p

Protocol for a MULTI-centre feasibility study to assess the use of ^99m Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study).

Autor: Warren H; Division of Surgery and Interventional Science, University College London, London, UK h.warren@ucl.ac.uk.; Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK., Wagner T; Department of Nuclear Medicine, Royal Free Hospital, London, UK., Gorin MA; Milton and Carroll Petrie Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Rowe S; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Holman BF; Department of Nuclear Medicine, Royal Free Hospital, London, UK., Pencharz D; Department of Nuclear Medicine, Royal Free Hospital, London, UK., El-Sheikh S; Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK.; Department of Pathology, Royal Free Hospital, London, UK., Barod R; Division of Surgery and Interventional Science, University College London, London, UK.; Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK., Patki P; Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK., Mumtaz F; Division of Surgery and Interventional Science, University College London, London, UK.; Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK., Bex A; Division of Surgery and Interventional Science, University College London, London, UK.; Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK., Kasivisvanathan V; Division of Surgery and Interventional Science, University College London, London, UK., Moore CM; Division of Surgery and Interventional Science, University College London, London, UK.; Department of Urology, University College Hospital, London, UK., Campain N; Department of Urology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Cartledge J; Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Scarsbrook A; Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Hassan F; Department of Nuclear Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK., O'Brien TS; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Stewart GD; Department of Surgery, University of Cambridge, Cambridge, UK., Mendichovszky I; Department of Radiology, University of Cambridge, Cambridge, UK.; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Dizdarevic S; Department of Nuclear Medicine, University Hospitals Sussex NHS Foundation Trust, Worthing, UK.; Brighton and Sussex Medical School, Brighton, UK., Alanbuki A; Department of Urology, University Hospitals Sussex NHS Foundation Trust, Worthing, UK., Wildgoose WH; Patient Representative, London, UK., Wah T; Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Vindrola-Padros C; Rapid Research, Evaluation and Appraisal Lab (RREAL), Department of Targeted Intervention, University College London, London, UK., Pizzo E; Department of Applied Health Research, University College London, London, UK., Dehbi HM; Institute of Clinical Trials and Methodology, University College London, London, UK., Lorgelly P; Department of Applied Health Research, University College London, London, UK., Gurusamy K; Division of Surgery and Interventional Science, University College London, London, UK., Emberton M; Division of Surgery and Interventional Science, University College London, London, UK.; Department of Urology, University College Hospital, London, UK., Tran MGB; Division of Surgery and Interventional Science, University College London, London, UK.; Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK.

Publikováno v: BMJ open [BMJ Open] 2023 Jan 24; Vol. 13 (1), pp. e067496. Date of Electronic Publication: 2023 Jan 24.